| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.4 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |